Pharmaceutical Continuous Manufacturing Market 2024-2028
The pharmaceutical continuous manufacturing market is forecasted to grow by USD 548.94 mn during 2023-2028, accelerating at a CAGR of 12.74% during the forecast period. The report on the pharmaceutical continuous manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, evolving API manufacturing scenario in developing countries, and increasing adoption of sustainability in pharmaceutical industry.
Technavio's pharmaceutical continuous manufacturing market is segmented as below:
By Application
- Final drug product manufacturing
- API manufacturing
By Product
- Integrated systems
- Semi-continuous systems
- Controls or software
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the growing digitalization and integration of industry 4.0 in continuous manufacturing as one of the prime reasons driving the pharmaceutical continuous manufacturing market growth during the next few years. Also, increasing demand for continuous manufacturing in biopharmaceutical industry and growing trend of outsourcing and contract manufacturing will lead to sizable demand in the market.
The report on the pharmaceutical continuous manufacturing market covers the following areas:
- Pharmaceutical continuous manufacturing market sizing
- Pharmaceutical continuous manufacturing market forecast
- Pharmaceutical continuous manufacturing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceutical continuous manufacturing market vendors that include Chemtrix BV, Continuus Pharmaceuticals, Coperion GmbH, Corning Inc., Dr. Helmut Rothenberger Holding GmbH, Eli Lilly and Co., Freund Vector Corp., GE Healthcare Technologies Inc., GEA Group AG, Gebruder Lodige Maschinenbau GmbH, Gericke AG, Honeywell International Inc., Hosokawa Micron Corp., Hovione, KORSCH AG, L.B. Bohle Maschinen und Verfahren GmbH, LMT Group, Novartis AG, Pfizer Inc., Siemens AG, SK Inc., Syntegon Technology GmbH, and Thermo Fisher Scientific Inc.. Also, the pharmaceutical continuous manufacturing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.